Podcasts about Tandem

Other Episodes You Might Like: Previous Episode - From Your Mouth to Your Gut: Hearing Health Whisper Next Episode - The Truth About Muscle and Menopause: What Every Woman Needs to Know About the Science Data More Like This - Take a Walk with a 57-year old Book Author | Just 1400 Miles    Resources: Join the Hot, Not Bothered! Challenge for your best start, restart or reset in or after menopause with 10 Days of coaching, short workouts, and clarity on how to exercise optimally. Flipping 50 Womens Retreats helps you step out of routine, challenge your body and mindset, and rediscover how you want to live midlife—supported by fitness, hormones, nutrition, and women just like you.   Date night for this couple is riding tandem on a bike for 80 days.  Even “uncoupled” and singles will enjoy this episode of inspiration. Disclaimer, you're going to want to dream bigger, take a risk, believe in yourself and have adventures after listening to this episode.  We've got some ideas for you! Check out the 2026 women's retreats here. This episode is about more than riding tandem with your partner. Prepare to be inspired.    My Guest: Lady JB Owen is an internationally bestselling author, award-winning businesswoman, celebrated humanitarian, coveted speaker, trainer, and legacy mentor. She's been recognized by Forbes, Entrepreneur Magazine, and Apple News for her mission-driven work in publishing and impact.  Peter Giesin is the co-founder and CTO at Ignite Publishing, Software Evangelist for Aspiring Authors, Author, and Adventurer. He merges technology with storytelling to empower aspiring authors worldwide. Peter is ambitiously set on a personal goal: to live to 125 years old. He has an unwavering passion for exploring the far limits of living a long and vital life.   Connect with Lady JB & Peter: Website - Ignite Facebook - Ignite You and Epic Tandem Instagram - @igniteyou.life   Questions We Answer in This Episode: [00:12:16] You're currently cycling over 4,500 kilometers on a tandem bike to Ignite Humanity - define that.  [00:14:00] What inspired you to connect your purpose with a physically and mentally demanding challenge?  [00:20:00] How has the challenge changed over the years? With age, recovery changes, how has that hit differently?  [00:25:30] How do you stay motivated and connected to your ‘why' during the hardest parts of the journey, both physically and emotionally? [00:35:220] You're proving that shared purpose can strengthen not only communities but also relationships. What lessons have you learned about partnership, resilience, and communication while pedaling thousands of kilometers together? [00:45:56] People are inspired by your ride—what stories or people along the way have inspired you?  

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: kids' A1C and tech access correlation, first generic GLP-1 for weight loss approved, Metformin cuts long covid risk, Tandem Diabetes & Eversense updates, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Accessibility to modern diabetes technology directly correlates with A1c among children with type 1 diabetes globally. Big, cross-sectional study, conducted in 81 pediatric diabetes centers in 56 countries, found that a greater extent of reimbursement for continuous glucose monitoring (CGM), insulin pumps, glucose meters, and insulin was associated with lower A1c levels. Partha S. Kar, MD, Type 1 Diabetes & Technology lead of the National Health Service England, told Medscape Medical News, “As is now being shown in countries such as UK with widespread uptake of technology, there is now population-wide shift in A1c not seen before.”   He added, “If policymakers are serious about bringing A1c at a population level to sub-7.5% - 8% levels, then without technology it would be incredibly difficult to achieve, in my experience and opinion. Leaving the median A1c of a population at above 7.5%-8% goes with complications so that's a decision regarding investment many will have to make in the near future.”   In an accompanying editorial, Elizabeth R. Seaquist, MD, professor of diabetes, endocrinology, and metabolism and co-director of the Institute for Diabetes, Obesity, and Metabolism at the University of Minnesota, Minneapolis, called it “striking” that access to technology in and of itself was associated with improved glycemic control, given that multidisciplinary team care is also needed to provide education and behavioral or psychological support.     https://www.medscape.com/viewarticle/diabetes-tech-access-linked-a1c-kids-t1d-globally-2025a1000nn6 XX A man with type 1 in Illinois has received the first FDA-approved islet-cell replacement treatment, Lantidra, and  he is now producing his own insulin. The treatment works by restoring the body's beta cells, potentially eliminating the need for insulin injections.   The FDA approved Lantidra (donislecel) in 2023. Lantidra uses donor cells and requires lifelong immunosuppressive drugs.     Lantidra is only available at University of Illinois Chicago Health. Other universities, such as the University of Pennsylvania, continue to do islet cell transplants as part of clinical trials. Early data has shown that a majority of participants in the Lantidra clinical study were able to achieve some level of insulin independence, but it's unclear whether the benefits of donislecel outweigh the treatment's safety risks. Nearly 87 percent of participants reported infection-related adverse events, and post-operation complications included liver lacerations, bruising of the liver (hepatic hematoma), and anemia. One patient died of multi-organ failure from sepsis, which Lantidra maker CellTrans stated was “probably related” to the use of either immunosuppression or study drugs.   In addition, some industry leaders have raised the question of whether it's ethical to commercialize the use of deceased donor islet cells. https://diatribe.org/diabetes-research/first-fda-approved-islet-cell-transplant-performed?utm_campaign=feed&utm_medium=social&utm_source=later   XX Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk's injected Saxenda (liraglutide).   The compound, which is a GLP-1 forerunner of Novo's semaglutide products Ozempic and Wegovy, has been approved by the FDA to treat adults with obesity and those who are overweight and have weight-related medical problems.     Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds). The treatment is for both triggering and maintaining weight loss. Saxenda is not the first GLP-1 drug that is available as a generic. In June of last year, Teva also was the first company to launch a knockoff version of Novo's Victoza, which is the same compound as Saxenda but has been approved only for patients with Type 2 diabetes. Sales of the branded versions of both Victoza and Saxenda have declined significantly in recent years as demand for Novo's semaglutide and Eli Lilly's tirzepatide products have skyrocketed. In addition, marketers of compounded products have been aggressively competing for market share in the GLP-1 space. https://www.fiercepharma.com/pharma/saxenda-knockoff-teva-launches-first-generic-glp-1-obesity   XX Metformin could cut the risk of Long COVID by 64% in overweight or obese adults who started the drug within 90 days of infection. The large observational study, published in Clinical Infectious Diseases, analysed health records of over 624,000 UK adults with COVID-19 between March 2020 and July 2023. Among these, nearly 3,000 patients who began metformin treatment soon after diagnosis were tracked for a year. Compared to non-users, their likelihood of developing Long COVID, defined as persistent symptoms 90 days or more after infection, was dramatically lower. https://www.ndtv.com/health/metformin-cuts-risk-of-long-covid-by-64-why-the-diabetes-pill-is-not-for-everyone-9242332 XX Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don't know they have it, according to data analysis published Monday in the journal The Lancet Diabetes & Endocrinology. The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. “The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford , the lead author of the study.   “We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there's a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.” People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said. https://www.cnn.com/2025/09/08/health/diabetes-undiagnosed-half-of-americans-wellness XX A team of Hong Kong scientists is developing an injectable treatment that could potentially improve blood flow in diabetes patients' feet, in the hopes that it will reduce the need for amputation by rebuilding tissue in the arteries.   They also hope to apply the treatment to peripheral artery disease or PAD, a condition caused by the build-up of fatty deposits in arteries that affect blood circulation in the feet. “Traditional treatments for people suffering from poor blood flow in their legs are stent implantation or bypass surgery, which is invasive,” said Wong, who is also the co-founder of a biotechnology company called NutrigeneAI. He said it was his dream to turn research in the academic field into actual clinical treatments. But he added that the team still needed three to four years for further research on the treatment.   https://www.scmp.com/news/hong-kong/health-environment/article/3324671/hong-kong-scientists-developing-new-blood-flow-treatment-aid-diabetes-patients XX   Tandem Diabetes announces Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly upload their pump data to the cloud-based Tandem Source platform.1 The app is expected to be available later this year.   The Tandem t:slim mobile app will be available for compatible smartphones in the Apple App Store and Google Play store later in 2025. Once available, Tandem will email eligible customers with instructions on how to download and use the app.  https://www.businesswire.com/news/home/20250904665715/en/Tandem-tslim-Mobile-App-Now-Authorized-by-Health-Canada-for-iPhone-and-Android-Phones   XX Some changes to how the Eversense CGM will be rolled out.. right now it's being distributed by Ascensia Diabetes Care.  Senseonics will take back commercial control of the year long implantable CGM on January 1 in the US and expanding worldwide throughout 2026. The change was a mutual decision, according to the two companies, which said they have signed a memorandum of understanding before a definitive agreement is hammered out by the end of the year. To get started, Senseonics is also set to acquire members of Ascensia's commercial staff—including its CGM president, Brian Hansen, who is slated to become Senseonics' new chief commercial officer. https://www.fiercebiotech.com/medtech/senseonics-retake-eversense-cgm-commercial-control-ascensia-diabetes-care XX Utrecht-based medical device company ViCentra has closed an $85 million Series D round of funding led by Innovation Industries, along with existing investors Partners in Equity and Invest-NL. The round also drew support from EQT Life Sciences and Health Innovations.   The recent capital injection will be used to expand ViCentra's manufacturing capabilities, support regulatory approvals, and strengthen commercial rollout across Europe.   The funds will also be used to launch the next-generation Kaleido 2 patch pump in Europe and prepare for entry into the U.S. market.   The global insulin delivery market is growing quickly due to the increasing number of diabetes cases and demand for effective and user-friendly solutions. The market for insulin pumps is projected to exceed $14 billion by 2034. Patch pumps are the fastest-growing segment, signalling a trend toward compact and wearable devices. And here's where ViCentra is positioned to meet this need, offering a user-friendly, sleek design-led alternative to traditional systems.   Kaleido: design-led insulin delivery Kaleido is the smallest and lightest insulin patch pump developed as a lifestyle product with a particular focus on usability and personalisation.   Designed to feel more like personal technology than a traditional medical device, Kaleido features premium materials, and users can select their own favourite aluminium shells from a range of ten preset colour options.   It integrates with Diabeloop's hybrid closed-loop algorithms (DBLG1 and DBLG2) and is compatible with Dexcom CGM sensors, positioning it within the next generation of automated insulin delivery systems.   “Kaleido is a true disruptor — small, discreet, featherlight, and beautifully designed. It empowers people with diabetes by offering a more personal and distinctive choice in both function and style. Built with empathy and precision, it honours those who live with diabetes every day. With this funding, we can now meet surging European demand and fast-track our entry into the U.S. market. This is a pivotal moment — for ViCentra, and for the community we serve,” said Tom Arnold, Chief Executive Officer at ViCentra.   Improving the quality of life for diabetic patients ViCentra, led by Tom Arnold, is on a mission to improve the lives of those with diabetes.   The company reported that demand for Kaleido in Germany, France, and the Netherlands has already exceeded initial expectations.   ViCentra will present updates on Kaleido at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place September 15–19, 2025, in Vienna.   The company plans to engage with clinicians, investors, and strategic partners to further its role in the evolving diabetes care landscape.   “ViCentra is redefining insulin pump therapy with a platform that truly centres the user experience – combining clinical performance with design simplicity and wearability,” commented Caaj Greebe, Partner at Innovation Industries. “At Innovation Industries, we invest in pioneering companies that blend world-class technology with clear commercial potential. ViCentra exemplifies this by delivering a next-generation system addressing the urgent need for better treatment options in diabetes care. We're proud to lead this investment round and partner with Tom and the team as they deepen and expand their presence in Europe and prepare for U.S. entry.”   https://techfundingnews.com/dutch-vicentra-secures-85m-to-bring-insulin-patch-pump-to-more-markets/ XX Luna Diabetes announces they've raised more than 23-million dollars in early venture capital to help continue clinical trials and build out its capacity. This is the company that wants to offer a night time only, tiny, temporary insulin pump – to supplement insulin pen use. According to the company, more than 80% of the improvements in blood sugar from automated insulin delivery systems occur while the user is sleeping. Luna launched a pivotal trial late last year. https://www.fiercebiotech.com/medtech/nighttime-insulin-patch-pump-maker-luna-diabetes-raises-236m   XX Following 15 days and 150 fingerpricks, they're here. The results of the “9 sensor samba“. And what a set of a results…   Well maybe that's overplaying it a little.   Let's just say that the outcome of this n=1 experiment wasn't quite what I expected. One of the established players came out much worse than expected, while a newcomer did a lot better.   Let's dig in, and take a look at the variation. https://www.diabettech.com/cgm/the-nine-sensor-samba-results-revealed/   XX Hard work and perseverance define ranch life, but one man in eastern Montana takes it to another level. At 90, he's still living independently on the ranch he built from the ground up. Even more remarkable? He's a type 1 diabetic.   Bob Delp still begins each day just like he did decades ago, waking up on his ranch near Richey, Montana.   “I always thought if I could ever get a ranch and run a hundred cows, that's what I wanted to do from the time I was a kid,” said Delp.   He made that dream real, the hard way; after coming home from the army, he taught school, hayed for seven cents a bale and saved every cent he could.     “I worked at it real hard because I always felt like it was going to be part of getting me to that ranch that I always wanted,” said Delp.   He did it all while managing type 1 diabetes, a diagnosis that came with few answers and little hope back in the 1950s.   “The doctors tell me being a type 1 diabetic for 66 years isn't supposed to happen. Back then, it was a real challenge,” added Delp.   Statistically, it's almost unheard of. Fewer than 90 people in the world have lived more than 70 years with type 1 diabetes.     Bob credits his late wife, Donna, for helping him beat the odds.   “She has been key in that I always ate on time.”   They've faced their share of storms, both in health and out on the land. Not long after moving to Richey, a heavy snowstorm nearly tore everything apart just after they'd stepped out for dinner.   “If Donna hadn't said it was time to eat, we wouldn't have made it out of there. I guess that's one time that made me happy to have diabetes. And I think that saved us,” said Delp.     Now, he still checks his blood sugar daily but trusts his hands more than high-tech insulin pumps.   “I'm not satisfied with the sensors they have today. I just don't think they're accurate.”   To many, Bob's survival is extraordinary. To him, it's luck.   “The genes are there already, I can't change that so I guess I would have to say just lots of good luck,” said Delp.     And through it all, optimism has been his compass.   “You might fumble the ball, but if you're determined to be a winner, you'll recover that fumble someday,” said Delp.   He still welds nearly every day. Not because he has to, but because it keeps him going.   “As long as I keep doing something like this, I will not be in the nursing home,” said Delp.   https://www.kfyrtv.com/2025/08/09/against-all-odds-montana-man-thrives-with-type-1-diabetes-90/ XX Today, Dexcom is building on this belief and breaking new ground with the launch of its first open call across the U.S. and Canada in search of the next diabetes advocates—giving people with all types of diabetes a once-in-a-lifetime opportunity to raise awareness and share their voice on a global scale in the company's World Diabetes Day campaign (Nov. 14) and beyond.  Who is eligible?: Anyone age 2+ living with all types of diabetes or prediabetes can be nominated by themselves or by someone who knows them. Selected candidates will embody strength, advocacy and pride in living with diabetes or prediabetes. Where and how can I nominate myself or someone I know?: Visit Dexcom.com/WorldDiabetesDay When is the deadline to submit a nomination?: Nominations are open from September 10 through September 19 at 12pm PT. What will the selected candidates experience?:   An invite to participate in a World Diabetes Day photoshoot in Los Angeles to have their unique story featured in Dexcom's World Diabetes Day campaign The ongoing opportunity to attend events, connect with community, and raise diabetes awareness around the world XX The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more. The 61st annual EASD meeting will take place on September 15-19, 2025, in Vienna, Austria.   

Why Writing a Book in 2025 Is a Game-Changer for Entrepreneurs: Expert Insights from Book Coach Jennifer CrosswhiteIn today's fast-moving business world, standing out as a thought leader requires more than just expertise—it requires authority. In this episode of The Thoughtful Entrepreneur, host Josh Elledge sits down with Jennifer Crosswhite, seasoned book coach, editor, and CEO and Owner of Tandem Services Inc., to discuss why writing a book in 2025 is one of the most powerful moves an entrepreneur, coach, or CEO can make. Jennifer shares her experience navigating both traditional and self-publishing, revealing actionable strategies for turning your ideas into a book that builds credibility, influence, and lasting impact.Why a Book is Your Ultimate Authority ToolWriting a book in 2025 is not just about putting words on a page—it's about creating a strategic asset that can transform your business and personal brand. Jennifer emphasizes that a book functions as a tangible symbol of authority, often called a “$10 business card,” and provides a global platform for your message. Beyond credibility, books open doors to speaking engagements, media appearances, consulting opportunities, and strategic partnerships that would otherwise be out of reach.Another important point Jennifer makes is that publishing today is democratized. With self-publishing, hybrid models, and AI tools, entrepreneurs now have unprecedented access to producing high-quality content while directly connecting with their audience. AI can help with research, outlining, and drafting—but the unique voice and expertise of the author remain irreplaceable.Finally, a book is not about filling pages—it's about transformation. Jennifer stresses the importance of curating ideas, reverse-engineering your content for impact, and keeping your audience's journey front and center. When done strategically, a book becomes a tool to guide, inspire, and educate readers, creating measurable business growth and influence.About Jennifer CrosswhiteJennifer Crosswhite is a seasoned book coach, editor, and CEO and Owner of Tandem Services Inc., with extensive experience in traditional publishing, self-publishing, and coaching first-time authors. She helps entrepreneurs, thought leaders, and business owners craft books that establish authority, attract opportunities, and create lasting impact for readers and their businesses.About Tandem Services Inc.Tandem Services Inc. is a full-service coaching and publishing company dedicated to guiding authors from concept to published work. From strategic planning and outlining to editing and coaching, Tandem Services empowers business leaders to write books that not only position them as experts but also open doors to new opportunities, audiences, and revenue streams.Links Mentioned in this EpisodeTandem Services Inc. WebsiteJennifer Crosswhite on LinkedInKey Episode HighlightsWhy writing a book is the ultimate authority and credibility builder in 2025.How self-publishing and AI tools are changing the modern publishing landscape.Common misconceptions about book writing: it's not about page count, it's about transformation.Jennifer's two-step brainstorming process: brain dump and organization for maximum impact.The benefits of working with a book coach: accountability, expert feedback, and positioning your book for success.ConclusionWriting a book in 2025 is more than a creative project—it's a strategic business move that can set you apart, build authority, and expand your reach globally. Jennifer Crosswhite's...

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Zweistelliges Wachstum im Vertrieb – wie geht das in einem schwierigen Marktumfeld? Genau das gelingt Schäferbarthold, einem traditionsreichen Kfz-Teile-Großhändler. Im Gespräch mit Michael Möhrer, Vertriebsleiter bei Schäferbarthold, erfährst du, welches besondere Vertriebskonzept hinter diesem Erfolg steckt und warum es gerade in Zeiten des Umbruchs funktioniert. Stell dir vor, du bist in einer Branche unterwegs, die stark vom Wettbewerb geprägt ist und in der Margen und Kundenbeziehungen über alles entscheiden. Genau hier zeigt Schäferbarthold, dass nachhaltiges Wachstum im Vertrieb möglich ist – mit einer klaren Strategie, die sowohl auf persönliche Kundenbindung als auch auf ein innovatives Vertriebsmodell setzt. Ein Kernelement für das zweistellige Wachstum im Vertrieb ist das hybride Vertriebsmodell: Innen- und Außendienst arbeiten eng im Tandem zusammen. Während der Außendienst den persönlichen Kontakt zu den Kunden pflegt, übernimmt der Innendienst die tägliche Betreuung und schnelle Reaktionszeiten. Dieses Modell sorgt für Verlässlichkeit, Nähe und gleichzeitig Effizienz im Vertrieb. Das Besondere: Beide Rollen werden gleichwertig behandelt – ein klarer Unterschied zu vielen Mitbewerbern. Auch das Vergütungssystem ist einzigartig. Schäferbarthold setzt nicht mehr ausschließlich auf klassische Provisionsmodelle, sondern auf individuelle Zielvereinbarungen. So können neue Produktlinien gezielt gefördert und Mitarbeiter flexibel gesteuert werden. Das schafft Motivation und Klarheit – und fördert gleichzeitig gesunden Wettbewerb innerhalb des Teams. Ein weiterer Erfolgsfaktor für das zweistellige Wachstum im Vertrieb: persönliche Beziehungen. Während viele Unternehmen Angst haben, dass zu enge Bindungen zwischen Verkäufer und Kunde ein Risiko darstellen, sieht Schäferbarthold darin einen klaren Wettbewerbsvorteil. „Ich kaufe bei Manni“ ist hier keine Schwäche, sondern ein Beweis für Vertrauen und Verlässlichkeit. Die starke Bindung der Mitarbeiter ans Unternehmen sorgt zudem dafür, dass Kunden auch langfristig treu bleiben. Dazu kommt eine besondere Rolle im Vertrieb: der „Außendienstleiter“. Er ist kein klassischer Vorgesetzter mit disziplinarischer Macht, sondern ein Coach und Trainer, der Wissen weitergibt und neue Mitarbeiter begleitet. Dieses Modell fördert Wissenstransfer, Motivation und eine starke Vertriebskultur. Im Podcast sprechen wir auch über die Zukunft der Branche. Elektrofahrzeuge, alternde Fahrzeugbestände und eine zunehmende Konsolidierung im Aftermarket stellen Herausforderungen dar – gleichzeitig ergeben sich Chancen für Unternehmen, die flexibel und kundennah agieren. Schäferbarthold ist hier bestens aufgestellt und wächst seit Jahren zweistellig. Wenn du lernen willst, wie auch dein Unternehmen zweistelliges Wachstum im Vertrieb erreichen kann, dann solltest du in diese Episode unbedingt reinhören!  

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

#Engelsiz

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Wiebke ist mit dem Rad von Paris nach Hause gefahren — nach dem Krebs. Hedwig war bei der Deutschlandtour und Gerolf in Frankreich. (00:00:00) Begrüßung nach dem Urlaub und Rückblick auf August (00:04:07) Ausblick auf die Folge (00:04:54) Mit dem Fahrrad nach Paris – Wovon hat Wiebke geträumt? (00:06:50) Warum Paris? (00:07:43) Die Krankheitsgeschichte (00:11:31) Angepasste Ausstattung (00:12:58) Die Entscheidung: Let's go (00:15:04) Warum in Gegenrichtung? (00:15:47) Welche Räder? (00:17:01) Tourroute (00:20:49) Der schönste Moment (00:27:22) Reflexion und the Power of Radfahren (00:30:04) Hedwig – Kinderrennen zur Deutschlandtour (00:31:36) Warum hat Hedwig mitgemacht? (00:32:54) Der Streckenverlauf (00:34:36) Deutschlandtour quasi durch den Garten (00:35:33) Der schönste Moment (00:37:11) Nachgespräch Hedwig (00:38:50) Gerolf empfiehlt die Pyrenäen (01:01:44) Musik: Rival Schools – Good Things Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about WERBUNG Kloster Kitchen unterstützt euch Stück für Stück dabei, euer Wohlbefinden und eure Lebensqualität auf einfache und natürliche Weise zu verbessern. Für einen bewussten Lebensstil – Inspiriert von traditionellem Wissen und modernen Bedürfnissen. Mit dem Code ANTRITT15 erhaltet ihr 15% Rabatt auf alle Produkte (ausgenommen Abos und Gutscheine) auf www.klosterkitchen.de. Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-wiebke-nach-dem-krebs-hedwig-bei-der-deutschlandtour-gerolf-unterwegs

Send us a text- On-Demand Programme Link - https://mailchi.mp/bb2a7b851246/kairos-centreRemember our foundational question: 'Do you enter a conversation to be understood or to understand?'Communication is like a bicycle wheel. Picture the two of you riding along the road to your destination, but not getting very far because both wheels on your tandem bicycle are buckled. You will get to your destination, but not very fast and it is taking more effort to cover the distance. Now let's remove one of the bicycle wheels and take a look at what we have in front of us. We can view the hub in the middle and call it “communication”. The hub needs to be tight and work well, because attached to it are the spokes. The spokes are various life issues that we all face. Life will throw up lots of stuff that we have to deal with.Those spokes (or life issues) can be negotiated around and got over much better by the two of you where the hub (communication) is tight and working well for the two of you. How do we tighten the hub so that it keeps the spokes tightly attached to it and stop the wheel warping and hindering progress? The intention is to tighten up the hub so that when communication is working much better for the two of you, both of you can better tackle life issues. Let us look at the features of Communication. It includes body posture, gestures (such as head nods), facial expression, eye contact, physical proximity, appearance, style of speech, tone and volume of voice, words (and the different meanings they may have to you) and physical contact (such as hand shakes). Remember cultural differences and word nuances! The intention is that when therapy comes to an end, armed with new communication skills, each is better equipped to tackle those spoke issues which life will continue to throw up. Improved communication skill is a life skill which works in the home, work, gym or wherever interaction with another takes place.Sometimes we need to think outside of the box. Often we need a little help to see how we restrict our own thinking!  Get some help from The Kairos Centre. See what you cannot see. Begin to change that which you begin to better understand.Help someone to access the Recovery Programme: https://igg.me/at/ThekairosCentreHelp is here for you: bit.ly/pornaddictionhelpBritish Podcast Awards 2025: Consider voting for this Podcast? https://www.britishpodcastawards.com/votingGary McFarlane (BA, LLM, Dip, Certs), Accredited EMDR Practitioner.Keywords: sex addiction, addicted, sex counseling, partner, porn addiction, recovery, sex drive, sex addiction recovery, therapist, therapy, talk show, sex therapy, podcast, sobriety, counseling, relationships, relationship counseling, relationship advice, addiction, couples, relationship therapy, couples therapy, sex therapist, online counseling, emdr therapy, emdr, sex therapy, addiction, conflict management, love addiction, love addiction therapy, behavior, marriage, marriage advice, psychology, codependency, sex life, neuroscience, sex ed, sober, sobriety, sexual dysfunction, relationship issues, sex coach, sexual, sexual trauma, trauma, brain, sex science, The Sex Porn Love Addiction Podcast, biology, gender, Gary McFarlaneSupport the show

Wiebke ist mit dem Rad von Paris nach Hause gefahren — nach dem Krebs. Hedwig war bei der Deutschlandtour und Gerolf in Frankreich. (00:00:00) Begrüßung nach dem Urlaub und Rückblick auf August (00:04:07) Ausblick auf die Folge (00:04:54) Mit dem Fahrrad nach Paris – Wovon hat Wiebke geträumt? (00:06:50) Warum Paris? (00:07:43) Die Krankheitsgeschichte (00:11:31) Angepasste Ausstattung (00:12:58) Die Entscheidung: Let's go (00:15:04) Warum in Gegenrichtung? (00:15:47) Welche Räder? (00:17:01) Tourroute (00:20:49) Der schönste Moment (00:27:22) Reflexion und the Power of Radfahren (00:30:04) Hedwig – Kinderrennen zur Deutschlandtour (00:31:36) Warum hat Hedwig mitgemacht? (00:32:54) Der Streckenverlauf (00:34:36) Deutschlandtour quasi durch den Garten (00:35:33) Der schönste Moment (00:37:11) Nachgespräch Hedwig (00:38:50) Gerolf empfiehlt die Pyrenäen (01:01:44) Musik: Rival Schools – Good Things Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about WERBUNG Kloster Kitchen unterstützt euch Stück für Stück dabei, euer Wohlbefinden und eure Lebensqualität auf einfache und natürliche Weise zu verbessern. Für einen bewussten Lebensstil – Inspiriert von traditionellem Wissen und modernen Bedürfnissen. Mit dem Code ANTRITT15 erhaltet ihr 15% Rabatt auf alle Produkte (ausgenommen Abos und Gutscheine) auf www.klosterkitchen.de. Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-wiebke-nach-dem-krebs-hedwig-bei-der-deutschlandtour-gerolf-unterwegs

Wiebke ist mit dem Rad von Paris nach Hause gefahren — nach dem Krebs. Hedwig war bei der Deutschlandtour und Gerolf in Frankreich. (00:00:00) Begrüßung nach dem Urlaub und Rückblick auf August (00:04:07) Ausblick auf die Folge (00:04:54) Mit dem Fahrrad nach Paris – Wovon hat Wiebke geträumt? (00:06:50) Warum Paris? (00:07:43) Die Krankheitsgeschichte (00:11:31) Angepasste Ausstattung (00:12:58) Die Entscheidung: Let's go (00:15:04) Warum in Gegenrichtung? (00:15:47) Welche Räder? (00:17:01) Tourroute (00:20:49) Der schönste Moment (00:27:22) Reflexion und the Power of Radfahren (00:30:04) Hedwig – Kinderrennen zur Deutschlandtour (00:31:36) Warum hat Hedwig mitgemacht? (00:32:54) Der Streckenverlauf (00:34:36) Deutschlandtour quasi durch den Garten (00:35:33) Der schönste Moment (00:37:11) Nachgespräch Hedwig (00:38:50) Gerolf empfiehlt die Pyrenäen (01:01:44) Musik: Rival Schools – Good Things Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about WERBUNG Kloster Kitchen unterstützt euch Stück für Stück dabei, euer Wohlbefinden und eure Lebensqualität auf einfache und natürliche Weise zu verbessern. Für einen bewussten Lebensstil – Inspiriert von traditionellem Wissen und modernen Bedürfnissen. Mit dem Code ANTRITT15 erhaltet ihr 15% Rabatt auf alle Produkte (ausgenommen Abos und Gutscheine) auf www.klosterkitchen.de. Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-wiebke-nach-dem-krebs-hedwig-bei-der-deutschlandtour-gerolf-unterwegs

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Magazín: Kapela Brouci; tandem Solí země. Hovoří: Tamara Tomoszek, Eliška Sedláková, Tereza Brázdilová.Tento podcast můžete podpořit na https://radio7.cz

2 ans après Toni en famille, Nathan Ambrosioni, 26 ans, retrouve l'actrice Camille Cottin pour un nouveau film ensemble : Les enfants vont bien.Les Enfants vont bien a décroché ce week-end la plus haute récompense du Festival du film francophone d'Angoulême, le Valois de Diamant. Il y était présenté en avant-première et en compétition, avant sa sortie le 3 décembre 2025.Pour en savoir plus sur ce film très attendu, nous vous proposons de découvrir dès à présent notre échange avec le tandem Camille Cottin et Nathan Ambrosioni, enregistré au Festival d'Angoulême.Toni en famille, sorti en septembre 2023, a fait plus de 300 000 entrées et était une des jolies surprises de cette année. Il a connu un joli succès en salles, public et critique(avec une note Allociné de 3,9 côté presse, et 3,8 côté spectateurs).CréditsJournaliste : Brigitte BaronnetMontage : Constance Mathews Hébergé par Audion. Visitez https://www.audion.fm/fr/privacy-policy pour plus d'informations.

Hej på er, och varmt välkomna tillbaka till Blindtech support!Det är dags för höstens första avsnitt efter sommaruppehållet, och vi är taggade på att ta oss an en hel hög med nya och spännande ämnen. I det här avsnittet dyker vi ner i två lyssnarbrev, snackar om den smarta appen Billo och ger tips på hur du kan Swisha säkert. Vi tar också upp den populära chatappen Tandem, går igenom vad du ska tänka på när du köper en Bluetoothhögtalare, och pratar om dagboksappen One Day.Hoppas ni gillar avsnittet!Podden är indelad i kapitel som du kan bläddra mellan om din poddspelare stödjer denna funktion.Vill du få våra shownotes direkt till din inkorg? Mejla oss på:info@blindtechsupport.seTrevlig lyssning! Hälsar teamet bakom Blindtech Support.

In this episode, we're joined by Lukas Saari, CEO and Co-Founder of Tandem Health, the AI-driven platform transforming how clinicians and healthcare teams work together to deliver better patient outcomes. By combining customer obsession with advanced automation, Tandem Health empowers providers to streamline workflows, reduce administrative burden, and keep the human touch at the center of care. We spoke with Lukas about how AI is reshaping one of the most traditional industries and how Tandem Health has built trust with customers by deeply understanding their real-world pain points. Here are some of the key questions we address: How do you build trust with customers in industries where credibility and experience matter most? Why should commercial and product teams include people who've actually lived their customers' pain points? How does every new onboarding experience fuel product innovation? What role does deep customer understanding play in deciding where to take the product next? Why must SaaS founders think in terms of “jobs to be done” rather than features, and how does that mindset unlock customer value?

John Clark is the founder of Modern Shelving and Tandm Surf, two brands born from a simple idea: if he could sell it, his wife, an engineer, could build it. What started as a family-run shelving business evolved into a global Ecommerce company, while a day on the water with his daughter inspired an inflatable tandem surfboard that would later appear on Shark Tank.John's journey blends practicality with creativity. From solving everyday pain points with shelving to creating a patented surfboard that makes riding waves accessible to anyone, he's built businesses that reflect both lifestyle and innovation. Along the way, he's navigated the challenges of pitching on national TV, scaling niche products in the DTC market, and balancing multiple ventures without losing his entrepreneurial spark.Whether you're running a growing ecommerce brand or looking to turn family values into scalable business, John offers an honest look at what it takes to transform passion into products people love and companies that last.In This Conversation We Discuss:[00:37] Intro[01:21] Launching new products to fuel business growth[03:14] Adopting Google Adwords to drive early sales[04:00] Turning family traditions into a business idea[05:39] Making surfing accessible to everyone[07:07] Sharing prototypes at the beach for feedback[08:00] Pitching novelty ideas that capture attention[09:28] Episode Sponsors: Electric Eye, Heatmap, Grow[12:40] Answering what really happens after the deal[14:29] Leveraging the Shark Tank bump for growth[17:56] Using events to build brand visibility[19:06] Finding the right partner for long-term success[19:40] Patenting inflatable boards for portability[20:45] Building community beyond physical products[23:01] Encouraging entrepreneurs to think globallyResources:Subscribe to Honest Ecommerce on YoutubeVersatile designs + unique storage solutions for any space modernshelving.com/Shark Tark approved Tandem bodyboards and pool saddles tandmsurf.com/Follow John Clark linkedin.com/in/johngclarkSchedule an intro call with one of our experts electriceye.io/connectClear, real-time data built for ecommerce optimization heatmap.com/honestThe Premier Conference for Ecommerce Operators joingrow.comIf you're enjoying the show, we'd love it if you left Honest Ecommerce a review on Apple Podcasts. It makes a huge impact on the success of the podcast, and we love reading every one of your reviews!

One major outlet says the Texans' top receiving tandem isn't any better than 16th in the league — is that fair, and do they even need a true “tandem” to succeed? Plus, Figgy's Mixtape features catfishing for fishing hot spots, Macaulay Culkin on Home Alone, and more offbeat stories.

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, shared highlights on several major insulin delivery updates making waves at recent meetings. 00:00:00 Introduction 00:00:20 Pivot by Modular Medical 00:07:13 Medtronic's Partnership with Abbott - the Instinct Sensor 00:09:04 Tandem's One-Handed Insert 00:10:14 Tandem's Mobi Patch Pump

Tandem has built an impressive portfolio scaling from single-family homes to a 200-unit high-rise in Chicago's competitive market. To explain why Crain's took notice with a recent article about the firm, co-founders Tony Andrews and Dimitri Nassis share their remarkable journey with host Phil Coover. After reconnecting in an airport, the childhood friends partnered on their first profitable single-family project. “It was just very simple for me,” Tony recalls. “The accounting was simple. It's pluses and minuses and a little bit of division.” The duo expanded into multifamily developments, weathering the recession of ‘08 and Covid shut-downs. Tune in for their insights about vertical integration in development, the hidden profit strategies some general contractors use, and prioritizing transparency over traditional bidding battles. Connect and Learn More☑️ Dimitri Nassis | LinkedIn☑️ Tony Andrews | LinkedIn☑️ Tandem | LinkedIn | Facebook | YouTube☑️ Phil Coover | LinkedIn☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X☑️ Subscribe Apple Podcasts | Spotify | Amazon MusicThis podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed...

In the spotlight are book publicists and Tandem Literary business partners Gretchen Koss and Meg Walker, who have more than 40 years of combined experienced in the business. They have represented authors ranging from Elmore Leonard and Terry McMillan to Suze Orman, Mary Karr and Lance Armstrong.  We discuss:   >> What book publicists do >> How to choose the right publicist >> What they are expected to deliver to their clients >> When a publicist should be hired >> What book publicists expect of their clients >> The costs involved >> Which genres are hottest >> Etc.  Learn more about Tandem Literary here: https://tandemliterary.com/  Novelist Spotlight is produced and hosted by Mike Consol. Check out his novels here: https://snip.ly/yz18no       Write to Mike Consol at novelistspotlight@gmail.com 

In this powerful and transparent episode, we're joined by leadership coaches Mark and Christine Jewell, a dynamic couple leading the Momentum Company and Warriors of the Heart. What started as a business-focused meetup evolved into a candid conversation about marriage, money, calling, and the cost of doing life in parallel instead of in partnership. They share the raw truth of how merging their businesses and finances wasn't easy—but it was the key to unlocking a whole new level of peace, purpose, and profit in their home and company. Christine and Mark get vulnerable about their journey from individual success to shared purpose. They reveal how a word from God—“supernatural unification”—set them on a course that exposed hidden money habits, relational misalignment, and the danger of running side-by-side without real connection. By aligning their financial systems and embracing their God-given roles in life and business, they not only paid off nearly $300K in debt in 18 months, but also experienced explosive growth and deeper family unity. You'll walk away from this conversation with practical frameworks, spiritual encouragement, and renewed hope that you can build a life and business that thrives—together. Websites: https://www.thechristinejewell.com/ https://www.themomentumcompany.com/ Free Resource: Grab the Communication Cheat Sheet for deeper connection → https://www.thechristinejewell.com/communication-cheat-sheet For Christine's Book: Get the Book: Drop the Armor! Order direct for $200+ in bonus resources → https://www.thechristinejewell.com/drop-the-armor Ready for breakthrough? Apply for coaching and learn more about working with Christine here: https://www.thechristinejewell.com/apply Key Takeaways: Unification multiplies everything: When couples stop building separately and unite around a shared vision, momentum multiplies in marriage, business, and family. Money is a heart issue: Transparency, tithing, and structure helped them overcome shame and conflict, leading to financial breakthrough and joy in giving. Roles create freedom: Letting go of control and trusting each other's God-given strengths allowed them to operate in their genius without competition or burnout. Mark Bio: Mark Jewell is an internationally renowned leadership speaker and coach. As the co-founder and Chief Evangelist of The Momentum Company, an agribusiness focused leadership development company, Mark has worked with countless industry leaders around the globe. Over the past 20 years, Mark has partnered with major organizations like The Andersons, Verdesian Life Sciences, Purina, Cargill and more to facilitate training and help build high-performing teams. In addition to his speaking and coaching work, Mark hosts "The Intentional Agribusiness Leader Podcast"" where he shares actionable leadership insights with his growing audience. His conversations with industry leaders like Mike Borel, Colin Steen, Kip Pendelton, Hollie Bunn, Stephanie Liska and more provide listeners with tools and strategies to lead with more intention. Mark's insightful style has resonated with professionals across various industries. Mark is passionate about equipping the next generation of leaders. Through his keynote addresses, programs, and popular podcast, Mark is on a mission to impact ten million leaders. His goal is to spread his message of intentional leadership far and wide, helping both new and experienced professionals maximize their potential and achieve success on their own terms. Mark's expertise and experience have made him one of the most sought-after agribusiness leadership voices today. Christine Bio: Christine Jewell is an author, keynote speaker, and faith based executive coach with  over 25 years of experience in the fields of Health + Peak Performance, Entrepreneurship + Human Behaviour . She is also the host of the Breaking Chains Podcast. As the Founder of Warriors Of The Heart, she specializes in guiding highly successful CEO's and Impact driven leaders to break out of the superficial “life” they've built, redefine success and step into a whole new playing field grounded in eternal, life giving principles. Christine bridges the gap between the heart, fueled by faith & logic, fueled by practicality -  to help people receive more than they could ever imagine and claim the rich life they were created for. As a mother of 6, ages 9-23, through a blended family, a wife, high level athlete, multiple business owner and entrepreneur since her 20's, she is intimately familiar with the overwhelm and burnout that can come when building a ‘dream' life, as well as what's possible on the other side. Through years of trials, burning things down and rebuilding from the ashes of her past, she has ditched the rules of this world, following the calling on her heart to cultivate a life of total alignment - where there is more than enough time for her most meaningful work, extraordinary relationships, a legacy of impact - and plenty of rest! Her vision is to create a community of Kingdom Minded Men and Women who are rising together as powerful co-creators rather than competitors - and are redefining the way we lead at work, in relationships, and every arena of life! Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk

Tandem's Investment Team returns with Episode 21 of Tandem Talk! This discussion can be summed up into four words: a tug of war. And it's a tug on many levels—between the Administration and the Fed, between AI advances and the rest of the economy, a narrow market vs. a broadening market. Who will win the match?

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

When brand and product are treated as separate silos, user trust suffers. In this episode, Focus Lab CEO Bill Kenney and Max Q Co-Founder Lee Eisenbarth unpack what it means to build software experiences that feel cohesive—because they are.They explore how design systems, microcopy, onboarding flows, and even 404 pages can carry the weight of brand, not as decoration, but as the soul of the experience. You'll hear examples from companies like Slack, Linear, and Ledger, and leave with tactics to align product with purpose — even on a lean budget.Key Takeaways:Why brand-product misalignment kills trust (and how to fix it)Where to inject brand personality into the product — without overdoing itSmall but mighty ways to make technical UX feel humanHow internal teams (not just marketing) scale brand consistentlyWhether you're building your MVP or scaling a platform, this is your playbook for embedding brand into every corner of your product.Episode Resources:Learn more about MaxQ"Brand Isn't the Frosting. It's the Framework." (Article by Lee Eisenbarth)Connect with Lee on LinkedInPrint Magazine / Headspace Brand ArticleFocus Lab is an established B2B brand agency that believes, without question, that the most successful companies are the ones who invest in branding. Focus Lab creates transformative B2B brands that resonate with their customers and stand out as industry leaders. Through a proven process and a shared commitment to create unforgettable experiences, we develop true partnerships that help B2B brands become their boldest, most original selves.STAY IN TOUCH:Newsletter: https://focuslab.agency/subscribeLinkedIn: https://www.linkedin.com/company/focus-lab-llcInstagram: @focuslabllc Looking for a brand agency? We would love to hear from you. Email us: hello@focuslab.agency

Imagine cycling from Lands End to John O'Groats...on a folding bike! Well Listener Bobby Reading who has just set off to do exactly that.  JBobby's family sadly lost three grandparents in the space of just a few weeks and he is using the ride as a fundraiser for Care Rights UK. Follow Bobby via his instagram account - @bigbobsadventures and you can donate to his fundraiser here. We also hear from Tom and Gavin from @BlindlyCycling about being the first pair to attempt the Transcontinental Race on a Tandem bike.Watch my video all about Spectating at the Tour de France here.RedWhite Apparel - Check out the most comfortable bib shorts on the market! Support the showBuy me a coffee and help support the show! I'm an affiliate for a few brands I genuinely use and recommend including:

In this heartfelt and adventurous episode of Thriving in Tandem, Robert and Kay Lee Fukui take you behind the scenes of their dream trip through Italy—from Cinque Terre to Florence, Tuscany to Lake Garda. While the landmarks and landscapes were stunning, it was the lessons learned along the way that left the deepest impression. From learning to ask for help, to the value of simplicity, to taking the time to just be, the trip served as a powerful reminder of what truly matters—both in life and in business. They share stories of free Michelin-starred meals, ancient wine cellars, hiking coastal towns with just a carry-on, and why going slow created the richest experiences. But it wasn't just about sightseeing; it was about practicing margin, enjoying the moment, and bringing that same intentionality into their marriage and entrepreneurial journey. Whether you're dreaming of your next vacation or trying to find a better rhythm between business and family, this episode offers practical and soulful takeaways to help you thrive in tandem. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Key Takeaways: Ask Boldly, Expect Lightly: Robert shares how simply asking opened doors to unforgettable (and surprisingly free) experiences, reminding us that relationships matter in business and life. Pack Light, Live Light: Traveling with only carry-ons for 18 days taught the power of simplicity—and how less really can be more, even in the way we run our homes and businesses. Build in Margin: Whether on vacation or in your calendar, creating space to just be allows for connection, spontaneity, and soul-level rest that recharges you far beyond a to-do list.

Tandem est une tragicomédie française réalisée par Patrice Leconte, sortie en 1987. Lʹhistoire dʹune épopée radiophonique. Lʹhistoire de deux hommes, liés par le travail, lʹamitié, la servitude, lʹhabitude. Lʹhistoire dʹun jeu, de la campagne française, de la route, des bourgeois imbus dʹeux-mêmes, des beaufs, des questions avec réponses et des questions sans réponses. Tandem, est un road-movie écrit par Patrice Leconte, inspiré de la carrière de lʹanimateur radio Lucien Jeunesse et du jeu des mille francs. A lʹécran, Jean Rochefort incarne un animateur un peu ringard et dépassé, vieux beau flamboyant, Mortez, et Gérard Jugnot, Rivetot, son ingénieur du son, homme à tout faire, est son souffre-douleur et valet. Les deux hommes ne peuvent exister lʹun sans lʹautre. Ils sont un Tandem qui sillonne la France jusquʹà la déchéance de Mortez. Film subtil, où le malaise se glisse discrètement dans les dialogues, dans les situations rencontrées sur la route, ou pendant le jeu radiophonique, Tandem fait basculer Patrice Leconte dans la cour des grands cinéastes. En 1987, alors quʹon classe le réalisateur des Bronzés parmi les amuseurs publics, le voilà qui surprend tout le monde par la dimension dramatique de son film, par le côté Don Quichotte et Sancho Panza des personnages. Il faut dire aussi que ses comédiens sont exceptionnels : Jean Rochefort en zazou décati, véritable cabotin, et Gérard Jugnot que personne nʹattendait dans ce rôle tout en retenue et en émotion. Gérard Jugnot qui, pour lʹoccasion, se rase la moustache et porte une perruque pour cacher sa calvitie. Un nouveau physique qui le fait sʹévader du rôle de petit gros franchouillard et montre lʹétendue de son talent. Aujourdʹhui, dans Travelling, nous prenons la route avec Patrice Leconte et son Tandem de comédiens. Nous avons retrouvé beaucoup dʹarchives maison sur ce film. Nous les écouterons. Nous avons également comme source la biographie de Patrice Leconte, Je suis un imposteur, parue chez Flammarion. Dès lors, ne tardons plus. Ce nʹest pas le jeu de La langue au chat qui nous occupera, mais bien un émission radiophonique sur ce Tandem magnifique. REFERENCES Patrice Leconte, J'arrête le cinéma, Calmann-Lévy, 2011. Yves Alion (dir.) et Patrice Leconte, Tandem, un film de Patrice Leconte : découpage intégral et dialogues, Alice Éditions, coll. " L'Avant-scène Cinéma " (no 673), mai 2020 Patrice Leconte, Je suis un imposteur, Flammarion Tandem, bonus making-of https://www.allocine.fr/video/player_gen_cmedia=19589811&cfilm=2587.html Jugnot sur Tandem https://www.ina.fr/ina-eclaire-actu/video/bxc8707012335/cinema-interview-de-gerard-jugnot-au-sujet-du-film-tandem

In this conversation, Jared Prevost shares his journey into the real estate industry, discussing his initial interest sparked by a YouTube video and his subsequent experiences in wholesaling, flipping, and lending. He emphasizes the importance of building a sustainable business model and the advantages of midterm rentals. Jared also talks about his software company, Tandem, which supports real estate coaching, and his strategies for investing in properties across different markets. Professional Real Estate Investors - How we can help you: Investor Fuel Mastermind:  Learn more about the Investor Fuel Mastermind, including 100% deal financing, massive discounts from vendors and sponsors you're already using, our world class community of over 150 members, and SO much more here: http://www.investorfuel.com/apply   Investor Machine Marketing Partnership:  Are you looking for consistent, high quality lead generation? Investor Machine is America's #1 lead generation service professional investors. Investor Machine provides true ‘white glove' support to help you build the perfect marketing plan, then we'll execute it for you…talking and working together on an ongoing basis to help you hit YOUR goals! Learn more here: http://www.investormachine.com   Coaching with Mike Hambright:  Interested in 1 on 1 coaching with Mike Hambright? Mike coaches entrepreneurs looking to level up, build coaching or service based businesses (Mike runs multiple 7 and 8 figure a year businesses), building a coaching program and more. Learn more here: https://investorfuel.com/coachingwithmike   Attend a Vacation/Mastermind Retreat with Mike Hambright: Interested in joining a “mini-mastermind” with Mike and his private clients on an upcoming “Retreat”, either at locations like Cabo San Lucas, Napa, Park City ski trip, Yellowstone, or even at Mike's East Texas “Big H Ranch”? Learn more here: http://www.investorfuel.com/retreat   Property Insurance: Join the largest and most investor friendly property insurance provider in 2 minutes. Free to join, and insure all your flips and rentals within minutes! There is NO easier insurance provider on the planet (turn insurance on or off in 1 minute without talking to anyone!), and there's no 15-30% agent mark up through this platform!  Register here: https://myinvestorinsurance.com/   New Real Estate Investors - How we can work together: Investor Fuel Club (Coaching and Deal Partner Community): Looking to kickstart your real estate investing career? Join our one of a kind Coaching Community, Investor Fuel Club, where you'll get trained by some of the best real estate investors in America, and partner with them on deals! You don't need $ for deals…we'll partner with you and hold your hand along the way! Learn More here: http://www.investorfuel.com/club   —--------------------

In this action packed episode of Thriving in Tandem, we're joined by Raymond and Leslie Funk—ordained ministers, firearms instructors, and founders of Three Cord Marriage. With raw honesty and humility, they share their journey of rebuilding their marriage after infidelity, addiction, and emotional trauma. From living broken, worldly lives to leading a Kingdom-centered marriage ministry, their story is one of redemption, intentionality, and purpose. Raymond and Leslie pull back the curtain on how unhealed wounds and selfish expectations nearly destroyed their relationship—and how God met them at rock bottom. Through pastoral counseling, personal accountability, and a commitment to healing as individuals before fixing the marriage, they discovered how to reconnect, forgive, and thrive again. Now, they equip other high-performing couples with tactical tools—both spiritual and practical—to protect and strengthen their marriage. Listen in as we discuss the real work of rebuilding trust, the power of daily disciplines like prayer and shared vision, and how even firearms training became an unlikely but transformational way to reconnect. Whether your marriage is in crisis or simply needs a refresh, you'll walk away with hope and actionable strategies to protect what matters most.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: FDA approves the first fast-acting biosimilar insulin in the US, Tandem issues warning, DOJ stands up for remote monitoring in schools, GLP1 use protects against dementia, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX We've got the first and only biosimilar FDA approved and moving to market. Kirsty – insulin aspart, which is a biosimilar to Novolog will be available as a single-patient-use prefilled pen for subcutaneous use and a multiple-dose vial for subcutaneous and intravenous use. KIRSTY has been available in Europe and Canada since 2022. This same company makes Semglee, the first biosimilar for long acting? Sales of Insulin Aspart in the United States were approximately $1.9 billion in 2024, according to IQVIA. https://www.globenewswire.com/news-release/2025/07/15/3115973/0/en/Biocon-Biologics-Expands-Diabetes-Portfolio-with-FDA-Approval-of-Kirsty-the-First-and-Only-Interchangeable-Rapid-Acting-Insulin-Aspart-in-the-United-States.html XX Tandem Diabetes Care (Nasdaq:TNDM) has issued an urgent medical device correction for some t:slim X2 automated insulin pumps. In a July 22 notice, the San Diego-based company warned of pumps that may exhibit a higher rate of speaker failure. During normal use, the insulin pump software monitors current flowing through the speaker during use. Measurements that fall within a pre-determined range indicate a functioning speaker. Meanwhile, measurements falling outside the range indicate a speaker failure.   When the measurements land outside the expected range, the system declares a malfunction, referred to as “Malfunction 16.” If the pump declares this malfunction, insulin delivery will stop and the pump will no longer be operational. Malfunction 16 terminates communication between the pump and continuous glucose monitor (CGM), as well as the t:slim mobile app.   If not addressed, the issue can lead to hyperglycemia, which can result in hospitalization or medical intervention. The company reports 700 adverse events and 59 reported injuries to date, with no reports of death.   Tandem identified that certain speaker versions have a higher rate of Malfunction 16 events due to a wiring issue within the speaker. Users can continue using their pump but with added precautions because Malfunction 16 can occur at any time. They should use the t:slim mobile app with push notifications turned on so the app alerts them if the malfunction occurs, the company said.   Additionally, Tandem intends to release a software update aimed at enhancing the early detection of speaker failure. The update also introduces persistent vibration alarms to help reduce potential safety risk. Tandem plans to notify affected pump users when it makes the update available. https://www.drugdeliverybusiness.com/tandem-warns-insulin-pump-speaker-malfunction/ XX BIG WIN! The DOJ protects T1D rights again! The US Attorney's office for the Western District of Washington State reached a settlement with a public school district that once again confirms remotely monitoring students' CGMs is a reasonable accommodation that schools must provide to comply with the Americans with Disabilities Act. If its true for one state its true for all states under federal law! If your local schools still refuse to remotely monitor CGMs of their students, provide them with this letter to compel them to FOLLOWT1Ds and FOLLOW Federal Laws. If they still refuse contact us! https://followt1ds.org/ XX new study finds people taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin users. Past studies show that people who have type 2 diabetes — a chronic condition where the body does not use its insulin properly — are at a higher risk of developing dementia. The study found that when comparing the neuroprotective abilities of two diabetes medications — metformin and glucagon-like peptide-1 receptor agonists (GLP-1 agonists) — participants taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin.   https://www.medicalnewstoday.com/articles/glp-1s-may-offer-better-dementia-protection-than-metformin XX Front office changes coming to Dexcom.  CEO Kevin Sayer will step down  & give the reins to current Chief Operating Officer Jake Leach. Scheduled for January 1, 2026, Leach will also join Dexcom's board of directors where Sayer will remain  executive chairman. One of our frequent guests here.. Leach has worked at Dexcom for 21 years. He served as chief technology officer from 2018 to 2022 before he was named COO in late 2022. He was given the title of president in May. https://www.medtechdive.com/news/dexcom-ceo-change-kevin-sayer-jake-leach/756382/ XX A major international study has revealed that many children and young adults in Sub-Saharan Africa who are diagnosed with type 1 diabetes (T1D) may actually have a different, non-immune-based form of the condition. Unlike the traditional autoimmune version of T1D, this form appears to develop without the immune system attacking the insulin-producing cells. This finding could significantly reshape how diabetes is diagnosed and treated across the region, potentially leading to more precise care and better health outcomes. The researchers found that many young people in Sub-Saharan Africa diagnosed with T1D often don't have the usual markers in their blood (called islet autoantibodies) typically seen in people with T1D in other parts of the world. Specifically, 65% of participants with T1D in this region did not have islet autoantibodies. When the researchers compared this data to studies in the U.S., they found a smaller but significant proportion (15%) of Black participants diagnosed with T1D had a similar form of diabetes found in Sub-Saharan Africa – characterized by negative autoantibodies and a low T1D genetic risk score.   However, white Americans with T1D showed the typical autoimmune pattern, even if they didn't have detectable autoantibodies, their genetics still pointed to autoimmune diabetes.   “The identification of this T1D diabetes subtype in Sub-Saharan African populations and among individuals of African ancestry in the U.S. suggests a potential ancestral or genetic link,” Dabelea notes. “These findings highlight the need to consider alternative etiologies in this group and a deeper understanding of the underlying mechanisms may provide important insights for future prevention and treatment strategies.”     https://scitechdaily.com/new-diabetes-subtype-discovered-in-africa-challenges-global-assumptions/   XX Formal recognition for the specialty of Diabetology.   Diabetology is the specialty focused on the full continuum of diabetes care — encompassing diagnosis, treatment, prevention, technology integration, education, and cardiometabolic management. While it intersects with endocrinology, primary care, and public health, diabetology is uniquely defined by its depth and focus on diabetes alone.       The American College of Diabetology (ACD) is the national professional organization representing clinicians who specialize in diabetes care. ACD advances clinical excellence and education to improve the lives of those affected by diabetes. https://www.businesswire.com/news/home/20250725766248/en/American-College-of-Diabetology-Announces-Formal-Taxonomy-Classification-for-Diabetology   XX Tidepool announces cloud-to-cloud integration with Abbott's FreeStyle Libre portfolio. From the release: This integration allows people living with diabetes using the FreeStyle Libre portfolio to connect their data to their Tidepool account seamlessly. For healthcare providers, this means more comprehensive insights and streamlined workflows, with FreeStyle Libre systems data flowing continuously into the Tidepool Data Platform. https://www.tidepool.org/blog/abbott-freestyle-libre-integration-launched XX Stelo dexom ai food XX With high drug prices remaining an ongoing concern for U.S. politicians, Roche is considering following in the footsteps of some of its peers with a direct-to-consumer (DTC) model to cut out the middlemen.     About 50% of the money spent on drugs in the U.S. healthcare system goes straight to PBMs instead of the companies that create the medicines, Roche CEO Thomas Schinecker called out in a press conference on Thursday.   Bringing the drugs directly to the consumer could be a solution to positively impact pricing for patients “without destroying innovation,” Schinecker added on a separate Thursday call with investors, noting that the company has discussed the matter with the U.S. government and its Department of Health and Human Services. The pricing talks come after President Donald Trump inked a “Most Favored Nation” executive order in May, aiming to tie U.S. drug prices to lower prices in other developed nations. The plan was quickly called out by industry voices such as the PhRMA trade group, which labeled it a “bad deal” for U.S. patients. https://www.fiercepharma.com/pharma/roche-weighing-direct-consumer-drug-sales-ease-us-drug-pricing-woes-cut-out-pbms-ceo-says XX SAB BIO secures substantial $175M financing to advance T1D therapy with impressive investor lineup and extended cash runway until 2028. Most critically, this financing fully funds the pivotal Phase 2b SAFEGUARD study evaluating SAB-142 for delaying progression of autoimmune Type 1 diabetes in newly diagnosed patients. By extending the cash runway into mid-2028, SAB has effectively eliminated near-term financing risk and provided clear visibility through this crucial clinical trial and potential commercialization preparation. Participation from strategic investor Sanofi, along with new investors RA Capital Management, Commodore Capital, Vivo Capital, Blackstone Multi-Asset Investing, Spruce Street Capital, Forge Life Science Partners and Woodline Partners LP, and existing investors Sessa Capital, the T1D Fund, and ATW Partners         https://www.stocktitan.net/news/SABS/sab-bio-announces-oversubscribed-175-million-private-fwsf2t91ek4z.html   XX In a landmark 14-year study, researchers have found that artificially sweetened drinks raise the risk of developing type 2 diabetes by more than a third, significantly higher than those loaded with sugar. It challenges the long-standing perception of diet drinks being a healthier alternative and suggests they may carry metabolic risks of their own. In the first longitudinal study of its kind, led by Monash University, researchers tracked 36,608 participants over an average period of 13.9 years to assess how both sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) impacted health outcomes. The self-reported health data, from the Melbourne Collaborative Cohort Study, was drawn from participants aged 40 to 69 years at the time of recruitment.   What they found was that drinking just one can of artificially sweetened soda increased the risk of developing type 2 diabetes by 38%, compared to people who didn't consume these drinks at all. For those consuming the same amount of sugary drinks, the risk was 23% higher. This suggests there's more than obesity at play. The researchers believe this result is due to an independent metabolic effect, possibly gut microbiome disruption or a change in glucose metabolism.   While the study didn't identify which artificial sweeteners were at play,   Evidence suggests that artificial sweeteners can alter the composition and function of gut bacteria, leading to glucose intolerance – a precursor to type 2 diabetes. And that some sweeteners may trigger insulin release, desensitize metabolic responses over time, or confuse the body's glucose regulation system – even without actual sugar in the picture.   Another hypothesis is that regular exposure to the kind of intense sweetness that artificial products deliver may condition the body to anticipate sugar calories that never come, affecting appetite regulation, insulin sensitivity and broader metabolic pathways. However, the authors suggest that how sweeteners affect the gut microbiota and glucose regulation are the most likely drivers of increased diabetes risk.   https://newatlas.com/diet-nutrition/one-drink-diabetes-risk/ XX After months of deliberation, information gathering and public testimony, a state board unanimously agreed Monday that two common medications for type-2 diabetes and other conditions appear to pose an affordability challenge to the state and Marylanders.   The state Prescription Drug Affordability Board approved two resolutions saying that prescription drugs Jardiance and Farxiga likely pose an “an affordability challenge for the state health care system” and the state should look for ways to bring down those costs.   Health care advocates call the long-awaited resolution an “important first step” in the process in bringing down prescription costs for those on the state's health plan.       That milestone has been years in the making. Created in 2019 by the General Assembly, the Prescription Drug Affordability Board was slow to launch due in part to a veto from former Gov. Larry Hogan (R) amid pandemic-induced economic uncertainty in 2020 that delayed the board's formation. The board also cited out-of-pocket costs for consumers and state and local spending on those drugs as indicators that there may be an affordability challenge.   The board will now look at options to address the potential affordability challenge, which could include setting an upper payment limit on those drugs. But it's not clear when the state will see cost savings.   That said, some members of the health care system and the pharmaceutical industry say that policies such as upper payment limits could weaken access to life-saving drugs. Others say that the board has not engaged enough viewpoints from the health care industry. https://marylandmatters.org/2025/07/29/state-board-determines-two-type-2-diabetes-drugs-may-be-unaffordable/   XX One year after it was revealed that Chrissy Teigen and John Legend's son, Miles, was diagnosed with type 1 diabetes, Teigen is revealing how she's making her son feel more included. Teigen first opened up about her 7-year-old son's diagnosis after she and her two oldest kids, Miles and 9-year-old daughter Luna were at the 2024 summer Olympics cheering on Simone Biles. Teigen posted a photo of Miles and Luna holding up a sign. Also visible in the picture was the insulin pump on Miles' arm. Now, Teigen is sharing some insight into how she's making Miles more comfortable with having type 1 diabetes, including giving LeBron James' Barbie doll type 1 diabetes as well. In a video shared on Instagram, Teigen is seen taking the T1D Barbie, removing her insulin pump and gluing the pump onto LeBron James' Barbie. “Turning T1D Barbie into T1D Lebron James for my son,” Teigen captioned the video, revealing James is Miles' hero. 41 million followers https://www.yahoo.com/lifestyle/articles/chrissy-teigen-gives-lebron-james-154608782.html  

Julie Christeas is the founder and CEO of Tandem Pictures. Her recent films include NUKED, a comedy starring Justin Bartha and Anna Camp, and BLACK BEAR starring Aubrey Plaza, Christopher Abbott, and Sarah Gadon. She also Executive Produced three original, short-form comedy series for NBCU/Peacock, all are slated for release Spring 2025, and produces original short-form content for some of the biggest brands in the world -- Amazon, Chase Bank, Ford Motors, Netflix, Cadillac, and many more. In this interview, we talk about strategies for de-risking film projects, changes in indie filmmaking, how she finds talent and projects, and much more. As a special note, this was part of our new LIVE interview series in partnership with Buzztown, a community for serious screenwriters, where students also participated in this interview. You can learn more or join the waitlist here: https://www.scriptmastermind.com/pr Want more? Steal my first book, INK BY THE BARREL - SECRETS FROM PROLIFIC WRITERS, right now for free. Simply head over to www.brockswinson.com to get your free digital download and audiobook. If you find value in the book, please share it with a friend as we're giving away 100,000 copies this year. It's based on over 400 interviews here at Creative Principles. Enjoy! If you enjoy the podcast, would you please consider leaving a short review on Apple Podcasts? It only takes about 60 seconds, and it really helps convince some of the hard-to-get guests to sit down and have a chat (simply scroll to the bottom of your iTunes Podcast app and click “Write Review"). Enjoy the show!

In this eye-opening episode of Thriving in Tandem, Robert and Kay Lee share the single most common money mistake keeping countless married entrepreneurs from building real wealth: debt. Fresh off the facilitation of a financial stewardship workshop, they dig into how everyday debt—often justified or ignored—is quietly stealing your financial future. But here's the good news: the solution is simpler than you think. Spoiler alert: You have to listen til the end. You'll learn how debt is not just a financial burden, but a barrier to freedom, peace of mind, and legacy-building. Whether it's credit cards, car loans, or payday advances, this conversation explores the hidden costs of “buy now, pay later” culture and how breaking that cycle can unlock wealth potential that most couples never realize. They even run the numbers—showing how just $500/month invested wisely could grow into $1 million over time. If you've ever said, “We don't have enough to invest,” this episode will challenge that belief—and show you exactly how to create margin, eliminate debt, and finally start building long-term wealth together. Practical tips, real-life examples, biblical wisdom, and a strong dose of encouragement await. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Debt Repayment Calculator https://www.crown.org/all-resources/debt-snowball-calculator/ Investment/Retirement Calculator https://www.crown.org/all-resources/?cat=economy-investing&type=calculator  Key Takeaways: Debt is the true wealth killer. The average American carries over $20,000 in consumer debt, costing $1,500/month—money that could be building your future. Delayed gratification wins. Saving and paying cash—especially for big-ticket items like cars—can save you thousands and put you on the fast track to financial freedom. Simple strategy, massive results. The debt snowball method helps you eliminate debt faster than you think, freeing up cash for giving, investing, and enjoying life. Building wealth is more doable than you think. Just $500/month invested at 10% can become $1 million over 30 years—yes, really. Freedom from debt brings peace. No matter the economy, having no payments gives you breathing room, confidence, and options.

Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk In this deeply vulnerable and inspiring episode of Thriving in Tandem, we're joined by Krystal Parker, President of the U.S. Christian Chamber of Commerce. Krystal shares her raw journey from corporate executive climbing the ranks of a Fortune 200 oil and gas company to discovering the devastating cost of success when it came at the expense of her marriage and family. What looked like professional triumph on the outside masked a crumbling home life and personal disconnection from what mattered most. As Krystal takes us back to the peak of her corporate climb—fueled by power, ambition, and external validation—she candidly reveals the blind spots that hurt her marriage ending and relationship with her young daughter. But in the aftermath of that breaking point, Krystal discovered what true leadership and intentional living looked like. From restructuring her work-life rhythms to raising up her team, and ultimately placing God and family at the center, her story offers hope and a powerful reminder that redemption is possible. Whether you're in a season of hustle or navigating growing pains in business and marriage, Krystal's testimony is a call to evaluate where your time and heart are going. She shares practical boundaries she and her husband now implement, how she keeps her daughter a priority, and the critical difference between using work as worship instead of worshiping work. This is a must-listen for married entrepreneurs who don't want to succeed in business only to lose what truly matters most. Key Takeaways: Success without alignment can destroy what matters most. Krystal's corporate rise came with sacrifices she didn't fully see until her marriage and family unraveled. You are irreplaceable at work but you not at home. Delegating empowered Krystal's team and freed her to re-engage with her daughter and home life. Boundaries and intention create lasting connection. Krystal and her husband carve out intentional moments—even in busy seasons—to stay united and keep God at the center of their marriage. Chapters 00:00 Introduction to Thriving in Tandem Podcast 02:01 Crystal Parker's Journey in the Oil and Gas Industry 10:11 Challenges of Balancing Career and Family Life 12:00 The Turning Point: Becoming a Solo Parent 18:07 Finding Balance in a New Marriage and Career 23:53 Lessons Learned and Final Thoughts  

This week we break our recorders and record that lo-fi episode all the people want. But seriously we had some technical difficulties so hope our hot takes make it to your ears. Tour talk and Tim does Tandem shopping.  This podcast is also supported by the generous and amazing donors to the Wide Angle Podium Network, and buy Hammerhead cycling! Visit hammerhead.io to check out the Karoo cycling computer, and use code SLOWRIDE at checkout to get a Heart Rate strap for free! Find us, and other fantastic cycling podcasts on the Wide Angle Podium Network, at wideanglepodium.com! Check out the brand new WAP app available in the Apple and Android app stores! You can email us at theslowridepodcast@gmail.com

In this episode, Rebecca and Shaun sit down with Renee Bush, founder of Tandem, a consultancy for interior designers. She's the secret weapon behind the brand and business strategy at powerhouses like Studio McGee. Renee shares her journey from graphic and studio operations into honing a niche helping designers align business structure, brand identity, and marketing.They dive deep into how strategic clarity—knowing who you are, who you're talking to, and what you want—transforms client experience, marketing, pricing, and scale. Renee's wisdom around confident positioning, signature processes and aesthetics, and the importance of a North Star brand makes this a foundational listen for any designer ready to level up.In this episode they discuss:Renee's non-designer path: transitioning from graphic design/studio ops through Studio McGee into founding TandemWhat brand strategy actually means: values, tone, ideal client, mission, emotional deliverablesHow to uncover a designer's unique "North Star" that aligns brand, process, team and marketingThe power of signature processes or aesthetics as a form of positioningWhy confidence—especially in pricing—is the linchpin to attracting the right clientsHow small, strategic changes across branding, social media, press, and referrals generate exponential growthTailoring Instagram and content for your future ideal client without losing your current audienceChoosing between volume of smaller projects vs. fewer high-end ones—and ensuring profitability through smart systemsMentioned:Tandem – with-tandem.comThe Haven List workshop – thehavenlist.com/workshopTandem Instagram – instagram.com/with_tandemTandem Pinterest - pinterest.com/with_tandemEpisode 99 with Ali FaulknerEpisode 149 with Danielle ChiprutOur links:Subscribe and leave a review - Apple PodcastsLike, Comment, & Follow - Hot Young Designers Club InstagramRebecca's InstagramShaun's InstagramFor more information - Check out the websiteBecome a “Loyal Hottie” - Support us on PatreonDesign Resources - Check out our shopMentioned in this episode:Get 50% off your first year + a 14-day free trial with Sortly. https://sortly.com/hydc

In this deeply personal episode, Robert and Kay Lee invite you into their real-time decision-making process as they consider a cross-country move from California to North Carolina. Fresh off a month-long stay in Lake Norman, they share candid reflections on the conversations, emotions, and logistical considerations that come with such a significant transition. From the practical realities of moving and renting to the emotional weight of leaving behind familiarity and friendships, this episode reveals how they approach big decisions as a married couple and entrepreneurial team. Whether you're facing a business pivot, relocation, or other major life decision, you'll gain valuable insights on how to navigate change without unnecessary conflict. Robert and Kay Lee walk through the importance of “baby steps” in decision-making, how to test the waters before diving in, and how differing emotional responses between spouses can actually work together to bring clarity and peace. They also reflect on the value of community, intentionality, and leaning into God's guidance when the future feels uncertain. This episode is not just about moving houses—it's about building a life with intention, staying united through change, and creating space for wise, thoughtful decisions that serve both your marriage and business. Tune in for a behind-the-scenes look at how real-life married entrepreneurs process transition without growing apart. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Key Takeaways: Big transitions—whether in life or business—are best navigated in small, intentional steps. Differing emotional responses between spouses are normal and can be leveraged for better communication and mutual understanding. Creating a plan B and “testing the waters” reduces anxiety and sets you up for more confident decision-making. Don't rush into big changes—whether it's a move, business shift, or investment—without first confirming peace and unity as a couple. Community, intentional planning, and faith-driven discernment are key to thriving in tandem through seasons of change. Chapters 00:00 Introduction and Background on the Move 02:52 Exploring Lake Norman and Decision-Making Process 06:09 Testing the Waters: A Month in Lake Norman 08:54 Building Relationships and Community Connections 12:13 Emotional Aspects of Major Life Transitions 15:03 Decision-Making Styles in Relationships 17:56 Taking Baby Steps in Major Changes 20:48 Conclusion and Final Thoughts  

In this eye-opening episode, Dr. Catherine Toon sits down with Robert and Kay Lee Fukui—authors of Tandem: The Married Entrepreneurs’ Guide for Greater Work-Life Balance—to unpack the powerful intersection of faith, business, marriage, and ministry. Together, they explore how to stop sacrificing your family on the altar of achievement and instead walk in divine alignment that honors God, strengthens relationships, and allows business to flourish. From their deeply personal experiences growing up in ministry and entrepreneurial households, the Fukuis share how they overcame generational patterns of imbalance to cultivate a lifestyle of intentional connection, prayerful unity, and clear boundaries. You’ll discover the power of margin over hustle, learn how prayer and unity can bulletproof your marriage, and get practical strategies to harmonize your calling with your relationships. Whether you're navigating the challenges of married life, launching a business, or feeling the pressure to "do it all," this conversation will bring hope, healing, and practical wisdom. It's time to thrive in every area of your life—together. Episode Highlights: * Why sacrificing your family isn’t God’s best—and what to do instead * How to set boundaries and say “no” with confidence and peace * The key to unity in marriage decision-making (and why it matters more than you think) * Practical ways to build margin and maximize time and impact * The surprising divorce statistics among couples who pray together * How faith, intimacy, and purpose unlock success in both ministry and business * The freedom of letting peace lead—plus red flags to watch for in decision-making * Why God’s best is never rushed, pressured, or guilt-laden Website: https://marriedentrepreneur.co/perspectives Book: "Tandem: The married entrepreneurs' guide for greater work-life balance" Click here: https://www.amazon.com/Tandem-married-entrepreneurs-greater-work-life/dp/1953284833 FREE Protect Your Purpose Masterclass: * 3 Keys to Staying Inspired and Thriving in Your Calling to Align with Your God-Given Purpose Watch it now: https://mbl.catherinetoon.com/saveyourspot To support the ministry with tax-deductible donations: https://catherinetoon.com/support/ Please rate, review, share, and subscribe — a little thing that makes a big difference!! Thank you! Resources to Bless You: * "Marked by Love, Revised & Expanded Edition" (#1 Best Seller!): https://bit.ly/3UGeJBI * Get God, Male & Female? on Audible: https://amzn.to/49hzCIM * FREE “How to Hear God” eBook: https://bit.ly/3cTNb49 * FREE Chapter from Marked by Love: https://markedbylovebook.com/free-chapter/ * Explore more resources: https://catherinetoon.com Stay Connected and Share God’s Love! * Facebook: @CatherineToonMD * Instagram: @catherinetoon * Twitter: @CatherineToonMD * YouTube: @CatherineToon, MD

Send us a textTerry M Brown shares how her 3,102-mile journey across America on a tandem bicycle transformed her life and taught her powerful lessons about resilience, presence, and embracing challenges. From escaping an abusive relationship to finding new purpose as an author, her story demonstrates how stepping outside your comfort zone can reveal strengths you never knew you had.• Riding from Oregon to Washington DC on a tandem bicycle with her husband• Overcoming physical and emotional challenges throughout the journey• Learning to "never quit on a bad day" after pushing through difficult conditions• Finding the courage to "do hard things" even when faced with seemingly insurmountable challenges• Accepting that life's journey is rarely a straight line but rather a "tandem journey" filled with unexpected turns• Struggling with and learning to appreciate the importance of staying present• Discovering that success doesn't come from becoming someone else but from uncovering strengths already within• Applying these life lessons beyond the bicycle journey to other challenges like grief and personal growth• Converting the experience into "10 Little Rules for a Blissful-Butted Adventure" with guided journaling questions• Finding healing and purpose through adventure after escaping a 14-year abusive relationshipIf there's something big and bold you've been wanting to do, start taking steps toward it today. Don't keep your dreams on a bucket list—turn them into action plans and begin moving in that direction, because you never know what tomorrow will bring.Follow Teri M. Brown atHer websitehttps://www.terimbrown.com/Her Promoted Bookhttps://www.terimbrown.com/10-little-rules-dba.htmlYouTubehttps://www.youtube.com/channel/UCaQ6p-EOSGd1tEeWijQSl9ATwitterhttps://www.facebook.com/TeriMBrownAuthorPinteresthttps://www.pinterest.com/terimbrownauthor/Instagramhttps://www.instagram.com/terimbrown_authorLinkedinhttps://www.linkedin.com/in/TeriMBrown/TikTokhttps://www.tiktok.com/@terimbrown_authorSupport the showFollow your host atYouTube and Rumble for video contenthttps://www.youtube.com/channel/UCUxk1oJBVw-IAZTqChH70aghttps://rumble.com/c/c-4236474Facebook to receive updateshttps://www.facebook.com/EliasEllusion/Twitter (yes, I refuse to call it X)https://x.com/politicallyht LinkedIn https://www.linkedin.com/in/eliasmarty/

Episode 197: Continuous Glucose MonitoringWritten by William Zeng, MSIII, and Chris Kim, MSIII. University of Southern California.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Will: IntroToday we're exploring Continuous Glucose Monitoring, or CGM. We'll break down what CGM is, who benefits, how to access it, options available for our patients, the pros and cons, and a few final reflections on where this technology is heading. Chris, So what is CGM?Chris:Continuous glucose monitoring refers to the use of a small wearable sensor placed just under the skin to track glucose levels in real time throughout the day and night. These sensors measure glucose in the interstitial fluid and transmit readings to a receiver or smartphone at regular intervals, allowing for 24/7 glucose trend tracking. Will:CGM has been shown to improve glycemic control, increase “time in range,” and reduce hypoglycemia. Let's review some evidence.Chris:A 2023 meta-analysis published in Diabetes Technology & Therapeutics reported a mean Hemoglobin A1c reduction of 0.43% across multiple trials. Will:In people with Type 1 diabetes, the IMPACT and DIAMOND studies showed sustained improvement in Hemoglobin A1c and hypoglycemia reduction over 6–12 months. CGM use in insulin-treated Type 2 diabetes patients also resulted in significant benefits, including reduced variability and fewer severe glucose excursions. Chris:Clinically and economically, CGMs help prevent long-term complications such as cardiovascular disease, nephropathy, and retinopathy. Chris, What patients specifically benefit the most from CGM?Will: CGMs are most commonly indicated for people with Type 1 diabetes and for those with Type 2 diabetes who are using intensive insulin regimens—typically defined as multiple daily injections or insulin pump therapy. Chris:And what are the qualifications in order to be covered by insurance?Will:In the United States, Medicare covers CGM as durable medical equipment for qualifying patients, and coverage requires a prescription, documentation of insulin use, and regular follow-up. Most major private insurers—including Blue Cross, Aetna, UnitedHealthcare, Cigna, and Kaiser—follow similar guidelines. Coverage is generally granted for patients with Type 1 diabetes or insulin-requiring Type 2 diabetes who monitor glucose at least four times daily or use an insulin pump. Chris:Some plans require demonstration of hypoglycemia unawareness or frequent glucose variability. For patients not on insulin, OTC CGMs may be an option, but coverage is typically not provided. That said, new FDA decisions are allowing over-the-counter access to CGMs like Abbott's FreeStyle Libre and Dexcom's Stelo, expanding availability for lifestyle or preventive purposes.Will:[There are a lot of products on the market. Which are the main products and how are they different?]Chris:The three main players in the CGM space are Dexcom, Abbott (FreeStyle Libre), and Senseonics (Eversense), each with unique offerings.Let's start with Dexcom. Dexcom G7 is a real-time CGM system approved for both Type 1 and Type 2 diabetes. It combines a sensor and transmitter into one compact wearable patch worn on the abdomen or upper arm for up to 10 days. It updates glucose readings every 5 minutes and connects directly to a smartphone or Apple Watch via Bluetooth. Dexcom also integrates with insulin pumps like Tandem's t:slim and the Omnipod 5. Data can be shared with providers through Dexcom Clarity, which integrates into electronic medical records (EMRs) like Epic. OTC access is not yet available for DEXCOM G7, but a new non-prescription product called Dexcom Stelo is being rolled out in 2025, targeting non-insulin-using Type 2 patients. Dexcom Stelo will also offer 15-day wear, smartphone integration, and factory calibration. The estimated OTC cost for Dexcom Stelo is expected to be around $99 for a 15-day sensor, or about $198/month.Will:$200! Abbott FreeStyle Libre comes in several versions. The Libre 2 offers 14-day wear and requires users to scan the sensor with their smartphone or reader to retrieve a glucose value. It has optional real-time alarms for high and low readings and transmits data to LibreView, which can integrate with most EMRs. Libre 3 is a real-time CGM with 1-minute interval updates, Bluetooth transmission, and a slimmer profile. Libre sensors are widely used in primary care and available OTC for non-insulin users. Libre 2 sensors cost approximately $70–$85 for a 14-day sensor, while Libre 3 is slightly higher, around $85–$100 per sensor—totaling about $140–$200/month out of pocket without insurance.Chris:Senseonics Eversense E3 is the only implantable CGM on the market. It involves a minor in-office procedure to insert the sensor under the skin of the upper arm, which lasts up to 180 days (and a newer version, Eversense 365, lasts up to one year). A removable transmitter worn on top of the skin sends data every 5 minutes to a mobile app and vibrates for alerts. It requires 1–2 calibrations per day using a traditional fingerstick meter. It integrates with Eversense DMS software for physician monitoring. The total cost for Eversense depends on the insertion procedure and insurance, but cash pay for the full 6-month system is estimated at $2,400–$3,000, or about $400–$500/month including follow-up visits.Will:Additional lower-cost CGMs such as the Medtrum A6 TouchCare are available internationally and in select U.S. pilot programs. These devices offer 14-day wear, smartphone syncing, and daily calibration, but are not yet FDA-approved for wide use and lack full EMR integration.Chris:In terms of performance and value, Dexcom G7 offers the most advanced real-time feedback and integration, making it ideal for those on insulin pumps or needing tight control. Will:FreeStyle Libre offers the best affordability and convenience, especially for non-insulin users or those who prefer not to deal with constant alerts. Eversense offers a niche but compelling option for people who want to avoid frequent sensor changes. Chris, [Are there any downsides or risks that patients should be aware of before trying out CGM?]Chris:CGMs are generally safe and well-tolerated, but they do have limitations. Dexcom G7 has a known failure mode where sensors sometimes fail prematurely, often before the full 10-day duration. Some users have reported “signal loss” errors or random disconnections, especially when switching between phone models or operating systems. There are occasional reports of inaccurate highs or lows due to compression during sleep or dehydration. Though the G7 is factory-calibrated, abrupt changes in hydration or blood flow can affect its readings.Will:FreeStyle Libre systems, particularly Libre 2, require the user to scan the sensor to retrieve data unless alerts are enabled. These devices may be affected by vitamin C (ascorbic acid), which can falsely elevate glucose readings, and they do not currently allow for automated insulin delivery integration. Some Libre 2 users have noted adhesive-related rashes or spontaneous detachment. Libre 3, while more advanced, still may lose Bluetooth connection intermittently, particularly if the phone is out of range or the app is not running in the background.Chris:Senseonics Eversense carries procedural risks due to its implantable nature. Minor scarring or infection at the insertion site has been reported. The transmitter must be worn during waking hours to provide alerts, and users report anxiety over losing the transmitter since data logging is interrupted without it. Calibration is still required, which adds to daily tasks. Additionally, the sensor does not communicate with insulin pumps or closed-loop systems.Will:All CGMs can cause mild skin irritation from adhesive, particularly in users with sensitive skin. Alert fatigue is another consideration, as frequent low- or high-glucose warnings may cause stress or lead users to silence notifications entirely. Finally, relying solely on CGM without periodic fingerstick confirmation in symptomatic scenarios can be a risk, especially during rapid glucose changes.Chris:Conclusion[***] Continuous glucose monitors have reshaped the way we manage diabetes, offering unprecedented insight into glucose trends, diet responses, and insulin timing. While CGMs are not flawless, the technology continues to evolve. Will: If your patient is on insulin or struggling with glucose variability, consider whether CGM is right for your patient. For those not using insulin, consider newer OTC options like FreeStyle Libre or Dexcom Stelo, which offer accessible entry points without the need for prescriptions. As AI integration, longer sensor life, and non-invasive monitoring enter the market, CGM will only become more useful.Dr Arreaza: Personal experience with CGMs. I do not have diabetes, but I have a strong family history of diabetes (including father, 2 grandmas, and about 15 uncles, aunts, and cousins.)I wanted to try it so I could teach my patients about CGM. My first experience was with Freestyle Libre 2: Pros: Painless placement, easy to use, scanning with phone was easier than fingersticks.Cons: Required some assembling to be placed, mild discomfort at night, and nighttime alarms.Dexcom G7:Pros: No need for scanning, feels more stable in your armCons: High readings (had to calibrate for a more accurate reading)Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

Femi Abebefe & Jared Smith wrap up their NFL Head Coach-QB Tandem draft. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

9-10am Hour 4 - Joe DiBiase talks with Kyle Bailey about the Carolina Panthers and if they'll start to see some sort of success after past years of failure. Joe also talks about the importance of this year's goaltending tandem for the Buffalo Sabres and how much pressure is on Devon Levi to become an NHL goaltender.

SiriusXM NHL Radio and Daily Faceoff Analyst Carter Hutton joined OverDrive to discuss the headlines around the NHL, the tandem of Anthony Stolarz and Joseph Woll, the NHL CBA guidelines for goaltenders, Gavin McKenna committing to Penn State and the impact to the NCAA, Stuart Skinner's ceiling with the Oilers, the importance of a goaltending coach, Stolarz's contract number and more.

Brian and Marty talk about the Sabres goaltenders headed into the 2025-26 season.

What will the Sabres goaltending tandem look like in 2025? full 914 Mon, 07 Jul 2025 17:24:38 +0000 PibLCo2HNzFZTQJQsB5gylhsa3593IbQ sports Sabres Live sports What will the Sabres goaltending tandem look like in 2025? No radio station in the USA talks more hockey than WGR Sports Radio 550 and no radio station talks more Buffalo Sabres and NHL hockey better than us. Heard daily from 12PM-1PM on WGR and simulcast on MSG TV, Sabres Live goes deep into the corners everyday, breaking down the play and the players of every Sabres game. Plus, we take listeners around the NHL getting the inside scoop on all the top stories. 2024 © 2021 Audacy, Inc. Sports False https://player.amperwavepodcasting

In this episode, we welcome Dr. Justin and Dr. Courtney Mosley, a powerhouse chiropractic couple and owners of Music City Health Center, one of the largest natural health clinics in Middle Tennessee. They share their journey of building a business and marriage together, from their serendipitous meeting to navigating the challenges of working side by side. The Mosleys reveal how they learned to honor each other's strengths, set clear business boundaries, and scale their practice to achieve both professional success and personal balance. Dr. Justin, known as the Mindset Doctor, also takes us through his near-death experience and how it reshaped his purpose, leading him to impact lives beyond the clinic through speaking, coaching, and masterminds. Meanwhile, Dr. Courtney discusses the importance of prioritizing health, setting boundaries, and creating a sustainable business model that allows them to serve their community without sacrificing their well-being. They provide invaluable insights for married entrepreneurs on building a thriving business without burnout, leading by example, and making faith-driven decisions. Podcast: The Mindset Doctor https://podcasts.apple.com/us/podcast/the-mindset-doctor-podcast/id1676852153  Follow Dr. Justin on Instagram at @drjustinmosley and Dr. Courtney at @doccourtney Watch Dr. Justin's TED Talk on overcoming fear of public speaking: https://youtu.be/aImrjNPrh30?feature=shared Need chiropractic care in Nashville? Visit https://www.musiccityhealthcenter.com/ Key Takeaways: The power of aligning your business and marriage vision before starting a venture together. How learning from other entrepreneurial couples helped them navigate working as spouses. The importance of setting business boundaries to prevent burnout and maintain work-life balance. How Dr. Justin's near-death experience led to a mission shift and greater impact. The significance of honoring each other's strengths and hiring strategically to scale a business. Why faith and intuition should play a role in major business and life decisions. Bio Dr. Justin and Dr. Courtney Moseley are the owners of Music City Health Center, one of the largest natural health clinics in Middle Tennessee. Dr. Justin Moseley, known as The Mindset Doctor, is a 2-time TEDx speaker, international keynote speaker, and host of The Mindset Doctor Podcast. After surviving a near-death accident in 2018, he shifted his mission from transforming lives in his clinic to inspiring audiences worldwide. Dr. Justin empowers others to unlock their full potential, create next-level success, and leave a lasting legacy. Dr. Courtney is on a mission to empower women to reclaim their energy, balance their hormones, and rediscover the joy of living.  Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk

ITB's Eagles beat reporter Andrew DiCecco gives his insights and observations from covering the Eagles on a daily basis. #philadelphiaeagles #eagles #flyeaglesfly #nicksirianni #jalenhurts #tannermckee #kylemccord #saquonbarkley #ajbrown In this positional preview podcast series, he starts by looking at quarterback.